Medicamen Biotech shareholders and shareholding pattern

NSE: MEDICAMEQBSE: 531146Pharmaceuticals & BiotechnologySmall Cap

Medicamen Biotech Limited · Face value ₹10 · Listed Oct 1995 on BSE, Oct 2021 on NSE

₹254.25₹9.55 (3.62%)BSE ₹254.70

Share price at the NSE close on 28 Oct 2026. Previous close ₹263.80.

28 Oct: open ₹263.00, high ₹265.40, low ₹252.15

52-week range of traded prices to 28 Oct 2026

₹212.40Low, 29 Jun 2026₹447.65High, 25 Nov 2025

Delivery only: shares bought must be paid for in full, with no selling on the same day.

Market cap: ₹358 Cr1,991st largest listed
P/E: Earlier quarters restated in the year
P/B: 1.30
Dividend yield: 0.39%
ROCE: 3.7%
Debt to equity: 0.17
Volume, NSE: 15,399

Medicamen Biotech's shareholding pattern for Oct 2026, filed on 27 Oct 2026, with every filing from Dec 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.

Who owns Medicamen Biotech, filing by filing

Per cent of the company's shares.

27 Oct 2026 filing

Promoters42.57%
Foreign institutions4.35%
Indian institutionsNone
Governments0.05%
Individuals and others53.03%

Shareholding pattern, per cent, from Sep 2022

Promoters
Foreign institutions
Indian institutions
Governments
Individuals and others

Per cent	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026	Oct 202627 Oct
	45.51%	45.51%	46.87%	46.87%	46.66%	45.37%	46.02%	46.02%	44.53%	44.53%	44.77%	44.77%	44.77%	44.77%	44.77%	44.77%	44.77%	44.83%	44.83%	44.83%	43.60%	43.60%	43.60%	43.21%	43.21%	43.21%	43.21%	43.21%	43.21%	43.21%	42.99%	42.99%	42.99%	43.16%	40.46%	40.46%	40.46%	40.46%	40.46%	40.46%	42.57%
Indian promoters	45.51%	45.51%	46.87%	46.87%	46.66%	45.37%	46.02%	46.02%	44.53%	44.53%	44.77%	44.77%	44.77%	44.77%	44.77%	44.77%	44.77%	44.83%	44.83%	44.83%	43.60%	43.60%	43.60%	43.21%	43.21%	43.21%	43.21%	43.21%	43.21%	43.21%	42.99%	42.99%	42.99%	43.16%	40.46%	40.46%	40.46%	40.46%	40.46%	40.46%	42.57%
	54.49%	54.49%	53.13%	53.13%	53.34%	54.63%	53.98%	53.98%	55.47%	55.47%	55.23%	55.23%	55.23%	55.23%	55.23%	55.23%	55.23%	55.17%	55.17%	55.17%	56.40%	56.40%	56.40%	56.79%	56.79%	56.79%	56.79%	56.79%	56.79%	56.79%	57.01%	57.01%	57.01%	56.84%	59.54%	59.54%	59.54%	59.54%	59.54%	59.54%	57.43%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.83%	0.17%	0.19%	0.16%	0.21%	0.21%	0.11%	0.06%	0.06%	0.05%	0.12%	Under 0.01%	0.06%	0.02%	0.10%	0.07%	4.49%	4.35%
Foreign portfolio investors, category I	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.17%	0.19%	0.16%	0.16%	0.16%	0.06%	Under 0.01%	Under 0.01%	0.05%	0.12%	Under 0.01%	0.03%	0.02%	0.10%	0.07%	–	–
Foreign portfolio investors, category II	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.52%	0.00%	0.00%	0.00%	0.06%	0.06%	0.06%	0.06%	0.06%	0.01%	0.00%	Under 0.01%	0.02%	Under 0.01%	–	–	Under 0.01%	0.02%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.31%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	–	–	–	–	–	4.49%	4.33%
Overseas Corporate Bodies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.24%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.07%	0.06%
Veralogix holdings(pty) ltd	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	4.42%	4.27%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.13%	0.20%	0.20%	0.20%	0.20%	0.68%	0.99%	1.17%	1.17%	0.87%	0.69%	0.64%	0.59%	0.44%	–	0.40%	Under 0.01%	Under 0.01%
Mutual funds	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.00%	0.00%	0.00%	–	–	–	–	–	Under 0.01%	Under 0.01%
Alternative investment funds	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.13%	0.20%	0.20%	0.20%	0.20%	0.67%	0.99%	1.17%	1.17%	0.87%	0.69%	0.64%	0.59%	0.44%	–	0.40%	–	–
Non-bank lenders registered with RBI	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	–	–	–	–	–	–	–
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%	0.06%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%
Central government	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%	0.06%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	54.84%	56.42%	56.40%	56.43%	56.38%	55.90%	55.69%	55.78%	55.77%	56.04%	55.98%	58.84%	58.85%	59.03%	59.39%	59.02%	55.00%	53.03%
Resident individuals, up to ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	19.15%	19.16%	19.34%	19.41%	19.86%	20.28%	21.88%	22.05%	22.15%	22.75%	22.55%	21.83%	22.46%	22.55%	22.44%	24.48%	26.54%	26.00%
Resident individuals, over ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	11.79%	12.20%	12.15%	12.02%	11.95%	11.62%	10.08%	9.52%	10.29%	10.21%	10.80%	9.67%	10.88%	9.62%	9.65%	7.62%	6.61%	6.02%
Companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.93%	2.98%	2.64%	2.76%	2.37%	2.33%	2.54%	2.96%	3.19%	2.89%	2.54%	2.19%	1.96%	2.15%	2.60%	2.19%	2.07%	2.00%
Non-resident Indians	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.68%	0.64%	0.58%	0.57%	0.53%	0.49%	0.46%	0.40%	0.39%	0.41%	0.43%	0.44%	0.37%	0.79%	0.82%	0.95%	1.03%	1.00%
Foreign nationals	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	–	0.00%	–	–	Under 0.01%	Under 0.01%	Under 0.01%
Foreign companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	10.59%	10.59%	10.59%	10.59%	10.59%	10.59%	10.59%	10.54%	10.54%	10.54%	10.54%	14.30%	14.30%	14.30%	14.30%	14.30%	12.50%	12.05%
Investor education fund	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.92%	0.89%	0.89%	0.89%	0.88%	0.88%	0.87%	0.87%	0.87%	0.87%	0.87%	1.29%	1.29%	1.28%	1.26%	1.26%	1.26%	1.21%
Directors and their relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.48%	2.48%	2.48%	2.48%	2.48%	2.48%	2.48%	2.46%	1.60%	1.60%	1.60%	1.50%	–	0.76%	0.76%	0.76%	0.59%	0.50%
Key managers	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.83%	1.83%	1.83%	1.83%	1.83%	1.83%	1.47%	1.47%	1.45%	1.37%	1.34%	1.22%	1.20%	1.17%	1.17%	1.17%	1.15%	1.11%
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	4.47%	5.65%	5.90%	5.89%	5.89%	5.40%	5.32%	5.51%	5.31%	5.40%	5.32%	6.39%	6.38%	6.40%	6.39%	6.28%	3.25%	3.12%
Bodies Corporate	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.30%	–	–	–	–	–	–	–	–	–
Clearing Members	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.08%	0.01%	0.02%	Under 0.01%	–	Under 0.01%	–	–	–	–	–	–	0.23%	0.23%	0.01%	0.25%	0.08%	0.07%
Hindu undivided families	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	4.13%	4.15%	4.39%	4.39%	4.39%	3.89%	3.88%	4.08%	3.66%	3.66%	3.26%	3.06%	3.07%	2.99%	3.23%	2.84%	2.85%	2.74%
Overseas Corporate Bodies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.31%	1.31%	1.31%	1.31%	1.31%	1.31%	1.30%	–	1.30%	1.30%	2.68%	2.68%	2.68%	2.68%	2.68%	–	–
LLP	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.26%	0.18%	0.19%	0.19%	0.20%	0.20%	0.13%	0.13%	0.35%	0.44%	0.76%	0.65%	0.40%	–	0.47%	0.51%	0.32%	0.30%
Body Corp-Ltd Liability Partnership	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.50%	–	–	–	–
Promoter shares pledgedShare of the promoters' own shares	34.70%	34.70%	32.02%	32.02%	31.29%	31.29%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Shares in issue	1,05,18,606	1,05,18,606	1,10,70,000	1,10,70,000	1,13,76,000	1,17,00,000	1,17,00,000	1,17,00,000	1,17,00,000	1,17,00,000	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,22,16,600	1,26,51,100	1,26,51,100	1,26,51,100	1,26,51,100	1,26,51,100	1,26,51,100	1,26,51,100	1,27,14,600	1,27,14,600	1,27,14,600	1,27,14,600	1,35,62,815	1,35,62,815	1,35,62,815	1,35,62,815	1,35,62,815	1,35,62,815	1,40,62,815
Shares locked in	20,28,606	20,28,606	24,47,300	54,50,749	56,06,749	56,06,749	74,41,949	60,07,949	41,60,749	41,60,749	59,51,089	55,76,089	11,13,994	11,13,994	7,12,600	4,56,000	3,36,000	3,36,000	2,60,000	2,60,000	2,60,000	2,60,000	0	56,44,185	56,53,685	56,53,685	1,40,000	1,40,000	1,40,000	1,40,000	63,500	63,500	0	57,51,465	65,85,042	65,85,042	–	–	–	–	5,00,000
Promoters' shares locked in	15,43,840	15,43,840	19,45,234	35,27,289	36,47,289	36,47,289	53,84,489	53,84,489	35,48,289	35,48,289	54,69,489	52,69,489	8,57,394	8,57,394	4,56,000	4,56,000	3,36,000	3,36,000	2,60,000	2,60,000	2,60,000	2,60,000	0	52,66,095	52,66,095	52,66,095	1,40,000	1,40,000	1,40,000	1,40,000	0	0	0	54,87,095	54,87,095	54,87,095	–	–	–	–	5,00,000

Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of Medicamen Biotech shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

Shareholders	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026	Oct 202627 Oct
All shareholders	4,111	4,095	4,041	4,519	4,462	4,802	4,874	4,795	4,804	4,684	4,584	4,501	4,440	4,542	4,693	5,050	4,854	4,965	5,263	5,595	9,140	9,300	9,107	8,332	8,273	8,233	8,272	9,419	10,252	10,639	10,652	10,792	10,576	10,435	10,808	11,177	10,967	10,806	11,047	11,680	11,662
	3	3	3	3	3	3	3	3	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	1	1	1	1	1	1	1	1	1	1	1	1
Indian promoters	3	3	3	3	3	3	3	3	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	1	1	1	1	1	1	1	1	1	1	1	1
	4,108	4,092	4,038	4,516	4,459	4,799	4,871	4,792	4,802	4,682	4,582	4,499	4,438	4,540	4,691	5,048	4,852	4,963	5,261	5,593	9,138	9,298	9,105	8,330	8,271	8,231	8,270	9,417	10,250	10,638	10,651	10,791	10,575	10,434	10,807	11,176	10,966	10,805	11,046	11,679	11,661
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	5	3	2	2	2	2	3	2	3	2	2	2	2	2	2	2	3	3
Foreign portfolio investors, category I	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	3	2	2	1	1	2	1	1	1	2	1	1	1	2	2	–	–
Foreign portfolio investors, category II	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3	0	0	0	1	1	1	1	2	1	0	1	1	1	–	–	1	1
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2	0	0	0	0	0	0	0	0	0	0	–	–	–	–	–	2	2
Overseas Corporate Bodies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1
Veralogix holdings(pty) ltd	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3	3	3	3	3	4	3	3	2	1	1	2	1	1	–	1	2	2
Mutual funds	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	1	1	1	1	1	1	1	1	0	0	0	–	–	–	–	–	2	2
Alternative investment funds	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	1	1	1	1	1	2	2	2	2	1	1	2	1	1	–	1	–	–
Non-bank lenders registered with RBI	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1	1	1	1	1	0	0	0	0	0	–	–	–	–	–	–	–
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1
Central government	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	8,322	8,265	8,226	8,265	9,412	10,244	10,632	10,646	10,786	10,571	10,430	10,802	11,172	10,962	10,802	11,042	11,673	11,655
Resident individuals, up to ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	7,715	7,679	7,641	7,670	8,796	9,601	9,995	10,008	10,124	9,885	9,758	10,129	10,509	10,305	10,157	10,382	10,985	10,957
Resident individuals, over ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	31	32	31	30	30	31	30	28	30	31	32	29	32	28	27	19	21	20
Companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	87	88	85	89	82	84	88	99	109	121	107	104	100	93	94	93	100	98
Non-resident Indians	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	142	136	127	130	139	138	146	141	147	155	164	157	149	160	161	170	181	182
Foreign nationals	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	0	0	0	0	0	0	0	0	–	0	–	–	1	1	1
Foreign companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1	1	1	1	1	1	1	1	1	1	2	2	2	2	2	2	2
Investor education fund	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Directors and their relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2	2	2	2	2	2	2	2	1	1	1	1	–	1	1	1	1	1
Key managers	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2
	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	341	324	336	340	359	384	367	364	371	374	364	377	377	370	357	371	379	391
Bodies Corporate	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2	–	–	–	–	–	–	–	–	–
Clearing Members	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	26	4	6	2	–	2	–	–	–	–	–	–	4	5	1	6	3	3
Hindu undivided families	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	305	309	319	327	349	372	356	353	356	357	348	361	361	351	343	354	369	380
Overseas Corporate Bodies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2	2	2	2	2	2	2	–	2	2	2	2	2	2	2	–	–
LLP	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	10	9	9	9	8	8	9	9	13	15	14	14	10	–	11	9	7	8
Body Corp-Ltd Liability Partnership	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	12	–	–	–	–

Medicamen Biotech promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing of 27 Oct 2026; the largest is SHIVALIK RASAYAN LIMITED, 42.57%. The filing names 1 more member with no shares.Promoter buying and selling

Holder
SHIVALIK RASAYAN LIMITEDIndian companies, trusts and others	42.57%	59,87,095	8.35%

No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.

Largest public holders of Medicamen Biotech, filing by filing

Per cent, on the same shares as the split above.

Holder	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026	Oct 202627 Oct
PHARMADANICA A/SForeign companies	12.36%	12.36%	11.74%	11.74%	11.78%	11.45%	11.45%	11.45%	11.45%	11.45%	10.97%	10.97%	10.97%	10.97%	10.97%	10.97%	10.97%	10.97%	10.97%	10.97%	10.97%	10.97%	10.97%	–	10.59%	–	10.59%	–	10.59%	10.59%	10.54%	10.54%	10.54%	10.54%	9.88%	9.88%	9.88%	9.88%	9.88%	9.88%	9.53%
GINNERUP CAPITAL APSForeign companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.51%	1.24%	1.24%	1.24%	1.24%	1.24%	1.24%	1.24%	1.23%	1.23%	1.23%	1.23%	2.62%	2.62%	2.62%	2.62%	2.62%	2.62%	2.52%
INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRSInvestor education fund	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.29%	1.28%	–	–	1.26%	1.21%
RAJESH MADANKey managers	1.27%	1.27%	1.21%	1.21%	1.35%	1.32%	1.32%	1.32%	1.32%	1.32%	1.26%	1.26%	1.26%	1.26%	1.26%	1.26%	1.26%	1.26%	1.26%	1.26%	1.26%	1.26%	1.26%	1.22%	1.22%	1.22%	1.22%	1.22%	1.22%	–	1.21%	1.21%	1.21%	1.21%	1.14%	1.14%	1.14%	1.14%	1.14%	1.14%	1.10%
VIJAY AMICHAND SANGHVIResident individuals, over ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.02%	1.11%	1.11%	1.12%	1.08%
Veralogix Holdings(Pty) LtdForeign companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	4.42%	4.42%	4.42%	4.42%	4.42%	–	–
Investor Education and Protection Fund (IEPF)Investor education fund	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.26%	1.26%	–	–
Ritesh Kantilal OswalResident individuals, over ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.14%	1.15%	1.15%	1.15%	1.15%	–	–
Sanjay BansalDirectors and their relatives	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.66%	1.66%	1.66%	1.66%	1.66%	1.66%	1.66%	1.66%	1.60%	1.60%	1.60%	1.60%	1.60%	1.60%	1.60%	1.60%	1.60%	1.60%	1.60%	1.50%	–	–	–	–	–	–
Ashish ChughResident individuals, over ₹2 lakh at face value	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.09%	1.07%	1.07%	1.07%	1.06%	1.06%	1.06%	1.06%	–	–	–	–	–	–	–
Pharmadanic A/sForeign companies	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	10.59%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Om Prakash ChughResident individuals, over ₹2 lakh at face value	–	–	1.32%	1.32%	1.28%	1.25%	1.25%	1.25%	1.25%	1.25%	1.19%	1.19%	1.19%	1.19%	1.19%	1.19%	1.19%	1.19%	1.15%	1.15%	1.14%	1.14%	1.14%	1.09%	1.09%	1.09%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Kim Ginnerup ApsOther non-institutions	–	–	–	–	–	–	–	–	–	–	2.51%	2.51%	2.51%	2.51%	2.51%	2.51%	2.51%	2.51%	2.51%	2.51%	2.51%	2.51%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Niam International Private LimitedOther non-institutions	–	–	–	–	–	–	–	–	1.50%	1.50%	1.43%	1.44%	1.45%	1.45%	1.41%	1.15%	1.06%	1.00%	1.00%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Kedar Nath BansalResident individuals, over ₹2 lakh at face value	–	–	–	–	–	–	–	–	1.28%	1.07%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
TransitResident individuals, over ₹2 lakh at face value	–	–	–	–	–	2.77%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Rajender S DhawanOther non-institutions	1.60%	1.60%	1.52%	1.52%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Harsh BansalResident individuals, over ₹2 lakh at face value	–	–	1.36%	1.36%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
O P ChughResident individuals, over ₹2 lakh at face value	1.39%	1.39%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Manju BansalResident individuals, over ₹2 lakh at face value	1.05%	1.05%	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.

Who moved in the Oct 2026 filing

Against the Sep 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.

Individuals and others: PHARMADANICA A/S 9.53%, −0.35 pts; GINNERUP CAPITAL APS 2.52%, −0.10 pts; INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS 1.21%, −0.05 pts; 2 more moved